G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
G1 Therapeutics (Nasdaq: GTHX), a commercial-stage oncology company, has announced its upcoming second quarter 2024 financial results and business update webcast and conference call. The event is scheduled for Thursday, August 8, 2024, at 8:30 a.m. ET. Interested parties can register online to receive dial-in information and a unique PIN for the live conference call. While not mandatory, it's recommended to join 10 minutes before the event starts.
A live and archived webcast will be available on the company's website under the Events & Presentations page. The webcast will remain accessible for 90 days following the event, providing an opportunity for those unable to attend the live call to review the information later.
G1 Therapeutics (Nasdaq: GTHX), un'azienda di oncologia in fase commerciale, ha annunciato il prossimo webcast e conferenza telefonica riguardanti i risultati finanziari del secondo trimestre 2024 e un aggiornamento aziendale. L'evento è programmato per giovedì 8 agosto 2024, alle 8:30 a.m. ET. Le parti interessate possono registrarsi online per ricevere le informazioni per la chiamata e un PIN unico per la conferenza dal vivo. Anche se non è obbligatorio, si raccomanda di partecipare 10 minuti prima dell'inizio dell'evento.
Un webcast dal vivo e registrato sarà disponibile sul sito web dell'azienda nella sezione Eventi e Presentazioni. Il webcast rimarrà accessibile per 90 giorni dopo l'evento, offrendo a coloro che non possono partecipare alla chiamata dal vivo l'opportunità di rivedere le informazioni successivamente.
G1 Therapeutics (Nasdaq: GTHX), una empresa de oncología en etapa comercial, ha anunciado su próximo webcast y conferencia telefónica sobre los resultados financieros del segundo trimestre de 2024 y una actualización del negocio. El evento está programado para jueves 8 de agosto de 2024, a las 8:30 a.m. ET. Las partes interesadas pueden registrarse en línea para recibir la información de acceso y un PIN único para la conferencia telefónica en vivo. Aunque no es obligatorio, se recomienda unirse 10 minutos antes del inicio del evento.
Un webcast en vivo y grabado estará disponible en el sitio web de la empresa en la página de Eventos y Presentaciones. El webcast permanecerá accesible durante 90 días después del evento, proporcionando a aquellos que no puedan asistir a la llamada en vivo la oportunidad de revisar la información más tarde.
G1 테라퓨틱스(Nasdaq: GTHX)는 상장된 종양학 회사로서 2024년 2분기 재무 결과 및 사업 업데이트 웹캐스트와 컨퍼런스 콜을 곧 발표한다고 알렸습니다. 이 이벤트는 2024년 8월 8일 목요일 오전 8시 30분 ET로 예정되어 있습니다. 관심 있는 분들은 온라인으로 등록하여 통화 정보를 받고 라이브 컨퍼런스 콜을 위한 고유 PIN을 받아볼 수 있습니다. 필수는 아니지만, 이벤트 시작 10분 전에 참여하는 것이 권장됩니다.
이벤트 후 90일 동안 접속 가능한 라이브 및 아카이브 웹캐스트는 회사 웹사이트의 이벤트 및 발표 페이지에서 확인할 수 있습니다. 이 웹캐스트를 통해 생방송에 참여할 수 없는 분들도 나중에 정보를 검토할 수 있는 기회를 제공합니다.
G1 Therapeutics (Nasdaq: GTHX), une entreprise d'oncologie en phase commerciale, a annoncé son prochain webcast et conférence téléphonique concernant les résultats financiers du deuxième trimestre 2024 ainsi qu'une mise à jour de l'entreprise. L'événement est prévu pour jeudi 8 août 2024, à 8h30 ET. Les parties intéressées peuvent s'inscrire en ligne pour recevoir les informations de connexion et un PIN unique pour la conférence téléphonique en direct. Bien que cela ne soit pas obligatoire, il est recommandé de se joindre 10 minutes avant le début de l'événement.
Un webcast en direct et archivé sera disponible sur le site web de l'entreprise dans la section Événements et Présentations. Le webcast restera accessible pendant 90 jours suivant l'événement, offrant la possibilité aux personnes qui ne peuvent pas assister à l'appel en direct de revoir les informations plus tard.
G1 Therapeutics (Nasdaq: GTHX), ein kommerzielles Onkologieunternehmen, hat seine bevorstehenden finanziellen Ergebnisse für das zweite Quartal 2024 und die Geschäftsupdate-Webcast- und Telefonkonferenz bekannt gegeben. Die Veranstaltung ist für Donnerstag, den 8. August 2024, um 8:30 Uhr ET geplant. Interessierte Parteien können sich online registrieren, um Informationen zur Einwahl und eine einzigartige PIN für die Live-Konferenzschaltung zu erhalten. Obwohl dies nicht obligatorisch ist, wird empfohlen, 10 Minuten vor Beginn der Veranstaltung beizutreten.
Ein Live-Webcast und eine Aufzeichnung werden auf der Website des Unternehmens unter der Seite „Veranstaltungen und Präsentationen“ verfügbar sein. Der Webcast bleibt 90 Tage nach der Veranstaltung zugänglich, was denjenigen, die an der Live-Anruf nicht teilnehmen können, die Möglichkeit gibt, die Informationen später zu überprüfen.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., July 25, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate update for the second quarter of 2024 on Thursday August 8, 2024, at 8:30 a.m. ET.
To register for the event and receive a dial in number and unique PIN to access the live conference call, please follow this link to register online. While not required, it is recommended that you join 10 minutes prior to the start of the event. A live and archived webcast will be available on the Events & Presentations page of the company’s website: www.g1therapeutics.com. The webcast will be archived on the same page for 90 days following the event.
About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical company whose mission is to develop and deliver next-generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA® (trilaciclib). G1’s goal is to provide innovative therapeutic advances for people living with cancer. G1 is based in Research Triangle Park, N.C. For additional information, please visit http://www.g1therapeutics.com and follow us on X (formerly known as Twitter) @G1Therapeutics and LinkedIn.
G1 Therapeutics® and the G1 Therapeutics logo and COSELA® and the COSELA logo are trademarks of G1 Therapeutics, Inc.
G1 Therapeutics Contact:
Will Roberts
Communications Officer
Vice President, Investor Relations and Corporate Communications
(919) 907-1944
wroberts@g1therapeutics.com
FAQ
When will G1 Therapeutics (GTHX) release its Q2 2024 financial results?
How can investors access G1 Therapeutics' (GTHX) Q2 2024 earnings call?
Where can I find the archived webcast of G1 Therapeutics' (GTHX) Q2 2024 earnings call?
What time should I join G1 Therapeutics' (GTHX) Q2 2024 earnings call?
